CaboPoint and the Future of Renal Cell Carcinoma Trials: Sequencing, Biomarkers, and Strategy

Authors

Atulya A. Khosla, Department of Medicine, Corewell Health William Beaumont University Hospital, Royal Oak, MI, USA.
Ali Moradi, Department of Medical Oncology and Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
Karan Jatwani, Department of Hematology-Oncology, George Washington University Hospital, Washington, DC, USA. Electronic address: kjatwani@mfa.gwu.edu.

Document Type

Editorial

Publication Date

11-19-2025

Journal

European urology

DOI

10.1016/j.eururo.2025.11.001

APA Citation

Khosla, Atulya A.; Moradi, Ali; and Jatwani, Karan, "CaboPoint and the Future of Renal Cell Carcinoma Trials: Sequencing, Biomarkers, and Strategy" (2025). GW Authored Works. Paper 8084.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/8084

Department

Medicine